Navigation Links
UF researchers develop improved gene therapy agent
Date:5/19/2008

GAINESVILLE, Fla. Replacing one amino acid on the surface of a virus that shepherds corrective genes into cells could be the breakthrough scientists have needed to make gene therapy a more viable option for treating genetic diseases such as hemophilia, University of Florida researchers say.

Reporting in the journal Proceedings of the National Academy of Sciences today (May 19), UF geneticists say they have developed a new version of the adeno-associated virus used in gene therapy that works about 30 times more efficiently in mice than vectors scientists currently rely on.

The discovery could be the solution to a problem that has plagued researchers and doctors using AAV as a gene therapy vector how to administer enough of the gene-toting virus to yield a therapeutic benefit without triggering an attack from the bodys immune system, says Arun Srivastava, Ph.D., the George H. Kitzman professor of genetics and the chief of cellular and molecular therapy in the UF College of Medicine department of pediatrics.

AAV is considered ideal for gene therapy because it possesses the viral ability to infect cells yet does not lead to disease. But scientists discovered they had to administer trillions of AAV particles for the corrective gene to take root in a cells nucleus and begin working.

Based on our studies and those of others, its become clear that the reason you need so much is because about half the AAV particles get stuck in the cytoplasm, said Srivastava, the senior author of the study and a member of the UF Genetics Institute. It doesnt get to the nucleus very efficiently. The reason for that is obvious. AAV is seen by the body as an invading protein and it tries to block it.

The body mistakenly tags many AAV particles as junk proteins and sends them into cellular trash cans called proteasomes, where they are destroyed, Srivastava said. And a particular amino acid, tyrosine, is to blame.

Tyrosine has as pa
'/>"/>

Contact: April Frawley Birdwell
afrawley@ufl.edu
352-273-5817
University of Florida
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers document rapid, dramatic reverse evolution in the threespine stickleback fish
2. Stowers Institute researchers identify gene linked to vertebral defects in patient populations
3. Researchers discover architecture for fundamental processes of life
4. ASU researchers synthesize molecule with self-control
5. Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
6. Berkeley researchers identify photosynthetic dimmer switch
7. Magnet Lab researchers make observing cell functions easier
8. Researchers find way to make tumor cells easier to destroy
9. UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells
10. Researchers report the cloning of a key group of human genes, the protein kinases
11. UT researchers find link between advertising and increased tobacco use among Indias youth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...with their arboreal hosts. But new research sugges...of choice, the ants can get destructive to neighbo...ember issue of the American Naturalist , is the f...nd it reopens a centuries-old debate on the relati...in species of plants and trees have cozy relations...
(Date:11/5/2009)...ning grant in the amount of $2,756,719 by the Nati...uation Education and Research Training (IGERT) pro...to Kent State. The grant, which is funded under th...runs through 2014. , The grant funds an IGERT pr... sensing (EARS). The purpose of the program is to ...
(Date:11/4/2009)... hold the power to help militaries and munitions m...c waste on test sites. , Compounds known as nitr...rld War II and have been used in military munition...ten used to propel tank shells and act like a more... knowledge of their environmentally harmful effect...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2Switching early breast cancer patients to exemestane improves long term survival 57884 1Switching early breast cancer patients to exemestane improves long term survival 57884 2Prince Albert II of Monaco Foundation helps fund Field Museum conservation efforts in Peru 10013 1Prince Albert II of Monaco Foundation helps fund Field Museum conservation efforts in Peru 10013 2Julio Palmaz to Present at the 2009 TCT Conference 57879 1Julio Palmaz to Present at the 2009 TCT Conference 57879 2
...y Assistance (AOA), a comprehensive, multi-faceted..."cap" on out-of-pocket co-payments for cancer pati...h AOA, patients who are uninsured, underinsured, o...l receive help obtaining financial support for Amg...ng cancer is expensive and our industry needs to f...
...ully so your buddy can get some tail may seem like...rds, it also gives a fascinating peek into hard-wi...hed lizards spend their year on earth looking to r...evolution. An article in the May 9 edition of the ...ovides the first genetic evidence of a trait that ...
...oteins in the brains of individuals addicted to co...nd mechanisms that may one day lead to new treatme...rted in the current issue of Molecular Psychiatry,...mounts of 50 proteins and point to profound change...se, said Scott E. Hemby, Ph.D., of Wake Forest Uni...
Other Biology News:Amgen introduces comprehensive financial assistance programs for cancer patients 2Nice guys do finish first in lizards' evolutionary race 2High-tech research shows cocaine changes proteins and brain function 2
(Date:11/6/2009)...Intarcia Therapeutics, Inc. delivered two presenta...s delivery of exenatide) program for the treatment...echnology Meeting in San Francisco, CA: ,, (Log...FTU126LOGO ) ,, Continuous Subcutaneous Deliv...e, HbA1c and Reduces Weight in a 28-day Phase 1b S...
(Date:11/5/2009)... DSM Pharmaceutical Products today announced that ... Saint Jean D,Illac, France, where DSM will be the...for Galenix commercial products on a global basis....s development opportunities co-marketing Galenix d...f Galenix in drug product development and clinical...
(Date:11/5/2009)...Call/ -- BioSpecifics Technologies Corp. (Nasdaq: ...rst-in-class collagenase-based products, today ann... ended September 30, 2009. ,, "We were extreme...s Arthritis Advisory Committee unanimously recomme...M) for the treatment of Dupuytren,s disease, and w...
(Date:11/5/2009)...ineSmith Partners has signed an initial agreement ...d that mimics the structure of natural cancellous ...products by SpineSmith,s Research and Development ...fold represents a significant advancement in techn...for the delivery of adult stem cells for skeletal ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
... closing condition to merger with Raven ...ISCO, Calif., Dec. 20 VaxGen,Inc. (Pink Sheets: V... that,it has, along with Punk Ziegel and Company, ...on stock for quotation on the OTC Bulletin Board, ...the year under the symbol VXGN.,Further, VaxGen an...
...rma is pleased to announce the,fall conference lin...are,impacting the pharmaceutical industry today. T...tional and networking opportunities for Clinical,M... large to small,pharmaceutical, biotech and medica...on some of the featured events and highlights,from...
...Roche has Filed an IND With the US FDA for a ..., August 10 Genmab A/S (OMX: GEN),announced today...al New,Drug application (IND) with the US Food and...ed under the companies, collaboration. Genmab will... not influence Genmab,s,financial guidance for 200...
Other Biology Technology:VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 2VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 3VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 4Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharma's Fall Line Up! 2Roche Files IND for Second Genmab Antibody 2
Finnpipette BioControl Multichannel, 8 Channel 5-50ul from Thermo Scientific
Acl I (Psp1406 I) from New England Biolabs
Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems
Acc I from Takara Mirus Bio
Biology Products: